Founders Financial Securities’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-20,000	Closed	-$20.6K	–	494
2025 Q1	$20.6K	Buy	20,000 +10,000	+100%	+$10.3K	﹤0.01%	457
2024 Q4	$13.8K	Buy	+10,000	New	+$13.8K	﹤0.01%	433